Nicotine receptor partial agonists for smoking cessation

Cited by (750)

Items 501–600 of 750

1. Evaluation of varenicline usage on ventricular repolarization after smoking cessation
   Duygu İlke Yıldırım, Mert İlker Hayıroğlu, Neriman Ünal, Mehmet Ali Eryılmaz · 2018 · Annals of Noninvasive Electrocardiology
2. NHG-Standaard Stoppen met roken
   Niels Henrik Chavannes, J Kaper, Bernard D. Frijling, JR Van der Laan, PWM Jansen, S Guerrouj, A. J. M. Drenthen, Willem A. Bax, LA Wind · 2011 · Bohn Stafleu van Loghum eBooks
3. A preliminary study suggests that nicotine and prefrontal dopamine affect cortico‐striatal areas in smokers with performance feedback
   M. R. Lee, Courtney L. Gallen, Thomas J. Ross, Pradeep K. Kurup, Betty Jo Salmeron, Colin A. Hodgkinson, David A Goldman, Elliot A. Stein, Mary‐Anne Enoch · 2013 · Genes Brain & Behavior
4. Critical Limb Ischemia: Advanced Medical Therapy
   Mark G. Davies · 2012 · Methodist DeBakey Cardiovascular Journal
5. Study suggests varenicline safe and effective among adults with stable depression
   Paul M. Cinciripini, Maher Karam‐Hage · 2014 · BMJ Evidence-Based Medicine
6. Interventions for preoperative smoking cessation (Review)
   Thordis Thomsen, Nete Villebro, Ann Merete Møller · 2009 · Research at the University of Copenhagen (University of Copenhagen)
7. Role of nicotine receptor partial agonists in tobacco cessation
   Pratima Murthy, Nivedita Maity, Prabhat Chand · 2014 · Indian Journal of Psychiatry
8. Mineral composition, histomorphometry, and bone biomechanical properties are improved with probiotic, prebiotic, and symbiotic supplementation in rats chronically exposed to passive smoking: a randomized pre-clinical study
   Marcelo Fernandes Tribst, Letícia Rocha Magalhães, Ricardo Augusto Silva, Heliard Rodrigues dos Santos Caetano, Weber Gutemberg Alves de Oliveira, Marcos Natal Rufino, Rogéria Keller, Osimar de Carvalho Sanches, Mário Jefferson Quirino Louzada, Hermann Bremer‐Neto · 2019 · Ciência Rural
9. Influence of Prolonged Serotonin and Ergovaline Pre-Exposure on Vasoconstriction Ex Vivo
   Ériton Egídio Lisboa Valente, David Lee Harmon, James Levi Klotz · 2021 · Toxins
10. Smoking cessation in Asians: focus on varenicline
    Dan Xiao, Shuilian Chu, Chen Wang · 2015 · Patient Preference and Adherence
11. Clinical utility of varenicline for smokers with medical and psychiatric comorbidity
    Jon O. Ebbert · 2009 · International Journal of COPD
12. Efficacy of pharmacological methods used for treating tobacco dependence: meta-analysis
    Małgorzata Maria Bała, Wiktoria Leśniak, Lukasz Strzeszynski · 2008 · Polskie Archiwum Medycyny Wewnętrznej
13. Smoking cessation in primary care
    Sean P. David, Marcus Robert Munafo · 2008 · BMJ
14. Diretrizes sobre doença arterial periférica da Sociedade Brasileira de Angiologia e Cirurgia Vascular
    Fabiano Luiz Erzinger, Afonso César Polimanti, Daniel Mendes Pinto, Gustavo Braga Murta, Marcus Vinícius Martins Cury, Ricardo Bernardo da Silva, Rodrigo Bruno Biagioni, Sérgio Quilici Belczak, Edwaldo Édner Joviliano, Walter Junior Boim de Araújo et al. · 2024 · Jornal Vascular Brasileiro
15. Thoracic Society of Australia and New Zealand ( TSANZ ) Guidance for the Management of Electronic Cigarette Use (Vaping) in Adolescents and Adults
    Henry Marshall, Moya Vandeleur, Emma Dean, Christopher Barton, Nia Luxton, Kristin Carson‐Chahhoud, André Schultz, Janet B. W. Williams, Tahlia Grammatopoulos, Emily C.A. Stone et al. · 2025 · Respirology
16. Smoking Cessation: It Is Never Too Late
    Peter M. Nilsson, Karl‐Olov Fagerström · 2009 · Diabetes Care
17. Pharmacological intervention and abstinence in smokers undergoing cessation treatment: A psychophysiological study
    Yong Cui, Jeffrey M. Engelmann, Jonathan Z. Xian, Jennifer A. Minnix, Cho Y. Lam, Maher Karam‐Hage, Paul M. Cinciripini, Jason D. Robinson · 2017 · International Journal of Psychophysiology
18. Parental nicotine replacement therapy and offspring bronchitis/bronchiolitis and asthma – a nationwide population-based cohort study
    Yasmina Molero, Johan Zetterqvist, Paul Lichtenstein, Catarina Almqvist, Jonas Filip Ludvigsson · 2018 · Clinical Epidemiology
19. Exposure to varenicline protects against locomotor alteration in a MPTP mouse model of Parkinson's disease
    A. Ribeiro-Carvalho, P.H. Leal-Rocha, J. Isnardo-Fernandes, U.C. Araújo, Y. Abreu-Villaça, C.C. Filgueiras, A.C. Manhães · 2021 · Brazilian Journal of Medical and Biological Research
20. The Nicotinic Agonist Cytisine: The Role of the NH···N Interaction
    Raúl Aguado, Santiago Mata, Miguel Sanz‐Novo, Elena R. Alonso, Íker León, José L. Alonso · 2022 · The Journal of Physical Chemistry Letters
21. Short-term smoking cessation leads to a universal decrease in whole blood genomic DNA methylation in patients with a smoking history
    Junyi Shang, Xinran Nie, Yanan Qi, Jing Zhou, Yong Qi · 2023 · World Journal of Surgical Oncology
22. Net Improvement of Correct Answers to Therapy Questions After PubMed Searches: Pre/Post Comparison
    Kathleen Ann McKibbon, Cynthia Lokker, Arun Keepanasseril, Nancy L Wilczynski, Robert Brian Haynes · 2013 · Journal of Medical Internet Research
23. Use of Smoking Cessation Interventions by Physicians in Argentina
    Verónica Schoj, Raúl Mariano Mejía, Mariela Alderete, Celia Patricia Kaplan, Lorena Peña, Steven E. Gregorich, Ethel Alderete, Eliseo J. Pérez‐Stable · 2014 · The Journal of Smoking Cessation
24. Use of the Patient Health Questionnaire‐2 to Predict Suicidal Ideations in Patients Taking Varenicline
    Christopher M. Cowan, Jennifer S. Wink, Kent J. DeZee · 2012 · American Journal on Addictions
25. Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female rats
    Edward D. Levin, Brandon J. Hall, Autri Chattopadhyay, Susan K. Slade, Corinne Wells, Amir H. Rezvani, Jed E. Rose · 2016 · Psychopharmacology
26. Evidence-based policy making for health promotion to reduce the burden of non-communicable diseases in Moldova
    Florence Sécula, Séverine Erismann, Cerniciuc Carolina, Angel Chater, Lion Shabab, Fiona C. Glen, Ala Curteanu, Aliona Serbulenco, Natalia Silitrari, Daniela Demişcan et al. · 2020 · BMC Proceedings
27. Pharmacologic Principles
    Peter John Barnes · 2010 · Elsevier eBooks
28. Bénéfices cardiovasculaires du sevrage tabagique
    Daniel Thomas · 2009 · La Presse Médicale
29. Using a standardized follow-up program to improve coronary heart disease secondary prevention
    Yanjun Gong, Fan Yang, Tao Hong, Yong Huo · 2015 · The Anatolian Journal of Cardiology
30. Varenicline: quantifying the risk
    Brian S. Alper · 2011 · Canadian Medical Association Journal
31. Evidence of the effectiveness and safety of first-line smoking cessation pharmacotherapy
    Evangelia Liakoni, Neal L. Benowitz · 2021 · European Respiratory Society eBooks
32. Varenicline and Nicotine Replacement Therapy for Smokers Admitted to Hospitals
    Gregory R. Weeks, Rukshar K. Gobarani, Michael John Abramson, Billie Bonevski, Ashley R. Webb, Dennis Thomas, Eldho Mathew Paul, Muhammad Rehan Sarwar, Brian James Smith, Sharmilla Perinpanathan et al. · 2024 · JAMA Network Open
33. Nicotine Addiction in Schizophrenia, Availability of Better TreatmentOptions as are in General Population
    Saeed Ahmed, Reena Reena, Nuzhat Hussain, Rizwan Ahmed, Sharmeen Amin, Samreen I. Ahmed, Washdave · 2015 · International Journal of Emergency Mental Health and Human Resilience
34. Smoking cessation should have more emphasis within Tobacco Control? The case against
    Gérard Dubois · 2009 · Health Policy
35. Psychological Effects of Aromatherapy on Smokers With Depressive Tendencies During Smoking Cessation Treatment: Protocol for a Pre-Post Single-Arm Clinical Trial
    Akiko Hata, Maki Komiyama, Akihiro Yasoda, Hiromichi Wada, Hajime Yamakage, Noriko Satoh‐Asahara, Tatsuya Morimoto, Yuko Takahashi, Koji Hasegawa · 2022 · JMIR Research Protocols
36. Potential Costs and Benefits of Statewide Smoking Cessation in Pennsylvania
    Jill S. Rumberger, Christopher S. Hollenbeak · 2010 · The Journal of Smoking Cessation
37. Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study
    Carlos A. Jiménez-Ruiz, Marcos García-Rueda, Manuel A. Martinez Muñiz, Jacobo Sellarés, Maria A. Jiménez-Fuentes, Lourdes Lázaro Asegurado, Esther Rodríguez, Concepción Rodríguez-García, Oriol Armengol, Emilia Abad et al. · 2017 · Monaldi Archives for Chest Disease
38. Can primary care data be used to evaluate the effectiveness of tobacco control policies?: data quality, method development and assessment of the impact of smokefree legislation using data from the Health Improvement Network
    Lisa C Szatkowski · 2011 · Nottingham ePrints (University of Nottingham)
39. Completing the Audit Cycle: Comparison of Cardiac Risk Factor Management in Patients with Intermittent Claudication in Two Time Periods
    A.M. Wilson, Paul Bachoo, Ian A. MacKay, Kevin Cassar, Julie Brittenden · 2007 · European Journal of Vascular and Endovascular Surgery
40. Health care providers knowledge, attitude and practice of smoking cessation interventions in public health facilities in Kiambu county, Kenya
    Judy Gichuki · 2014
41. Tobacco Smoking Is a Medical Problem. We Ought to Treat It Like One
    Ravi Kalhan, John T. Wilkins, Brian L. Hitsman · 2017 · American Journal of Respiratory and Critical Care Medicine
42. Efficacy and safety of pharmacological intervention for smoking cessation in smokers with diseases: A systematic review and network meta‐analysis
    Xin Xing, Xue Shang, Xinxin Deng, Kangle Guo, E Fenfen, Liying Zhou, Yongsheng Wang, Chaoqun Yang, Kehu Yang, Xiuxia Li · 2023 · Journal of Evidence-Based Medicine
43. Changes in Alcohol Consumption During a Stop-Smoking Attempt and Differences Between Smokers Using Nicotine Replacement and Smokers Using Varenicline
    Dunja Przulj, Peter Hájek, Sarah J. Snuggs, Hayden J. McRobbie · 2017 · Nicotine & Tobacco Research
44. Effects of varenicline on lung tissue in the animal model
    Hilal Ermis, Hakan Parlakpınar, Hülya Elbe, Nigar Vardı, Alaadin Polat, Gazi Gülbaş · 2020 · Jornal Brasileiro de Pneumologia
45. Nicotine Dependence among College Students Uninterested in Smoking Cessation during the COVID-19 Pandemic: A Cross-Sectional Survey
    Makoto Aoike, Yukihiro Mori, Yuka Aoyama, Mamoru Tanaka, Hana Kozai, Yukihiro Shigeno, Hatsumi Kawamura, Masato Tsurudome, Morihiro Ito · 2023 · International Journal of Environmental Research and Public Health
46. Predictive Insights Into Exocrine Pancreatic Insufficiency in Chronic Pancreatitis and Autoimmune Pancreatitis
    Tomoyuki Tanaka, Takefumi Kimura, Shun‐ichi Wakabayashi, Takuma Okamura, Shohei Shigeto, Naoki Tanaka, Shohei Kondo, Ichitaro Horiuchi, Yasuhiro Kuraishi, Akira Nakamura et al. · 2024 · Pancreas
47. Adenosinergic System: An Assorted Approach To Therapeutics For Drug Addiction
    Kiran Kumar Akula, Kulkarni Sk · 2012 · Future Neurology
48. An Evaluation of a Novel Biomarker Feedback Intervention on Smoking Cessation: A Pilot Study
    Jamie Hetherington, Rosanne Coutts, Kade Davison · 2012 · The Journal of Smoking Cessation
49. Effects of Smoking and Need for Cessation: Biochemical and Pharmacological Feedback
    Manoranjan Adak · 2014
50. Smoking and Passive Smoking
    Russell V. Luepker · 2016 · Cardiovascular Innovations and Applications
51. How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis
    Kyla H Thomas, Deborah M Caldwell, Michael Nader Dalili, David Gunnell, Marcus Robert Munafo, Matt Stevenson, Nicky J. Welton · 2017 · BMJ Open
52. PLACE OF ELECTRONIC NICOTINE DELIVERY SYSTEMS IN THE THERAPY OF NICOTINE DEPENDENCE: A MODERN LOOK AT THE PROBLEM
    Осипов Дмитрий Александрович · 2018 · The Bulletin of Contemporary Clinical Medicine
53. Fumador internado? – A intervenção apropriada
    Paula Pamplona · 2007 · Revista Portuguesa de Pneumologia
54. Does sex alter the relationship between CYP2B6 variation, hydroxybupropion concentration and bupropion‐aided smoking cessation in African Americans? A moderated mediation analysis
    Meghan J. Chenoweth, Annie R. Peng, Andy Z. X. Zhu, Lisa Sanderson Cox, Nicole L. Nollen, Jasjit S. Ahluwalia, Neal L. Benowitz, Jo Knight, Walter Swardfager, Rachel Fynvola Tyndale · 2021 · Addiction
55. Assessing combined effects of varenicline and N‐acetylcysteine on reducing nicotine seeking in rats
    Rusty W. Nall, Lauren N. Beloate, Michael E. Meyerink, Tiffany Penaloza, Jade D. Doolittle, Brett Froeliger, Peter W. Kalivas, Constanza García‐Keller · 2022 · Addiction Biology
56. Insula deep rTMS and varenicline for smoking cessation: A randomized control trial study protocol
    Christine Ibrahim, Saima Malik, Mera S. Barr, Daniel M. Blumberger, Zafiris Jeff Daskalakis, Bernard Le Foll · 2022 · Frontiers in Pharmacology
57. Pharmacological smoking cessation of adults aged 30–50 years with COPD
    Dea Kejlberg Andelius, Ole Hilberg, Rikke Ibsen, Anders Løkke · 2022 · npj Primary Care Respiratory Medicine
58. Pulmonary prehabilitation and smoking cessation
    Stephanie Opusunju Ibekwe, Samhati Mondal, Abimbola O. Faloye · 2022 · Current Opinion in Anaesthesiology
59. Alcoholism and Substance Abuse
    Donald K Warne · 2017 · Elsevier eBooks
60. The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials
    Angela M. Haeny, Ralitza V. Gueorguieva, LaTrice Montgomery, Krysten W. Bold, Lisa M. Fucito, Ran Wu, Srinivas B. Muvvala, Allen Zweben, Stephanie S. O’Malley · 2021 · Addictive Behaviors
61. Moderne medikamentöse Unterstützung der Tabakentwöhnung
    Thomas Hering · 2008 · Der Internist
62. Tolérance de la varénicline en pratique courante
    Patrick Dupont, Claudine Gillet, M. Guérin, Sophie Kalamarides, Élisabeth Larinier, Claire Meignan, Aline Moreau, Claude Guillaumin, J. Perriot · 2009 · La Presse Médicale
63. How Do We Safely Get People to Stop Smoking?
    David Chi-Leung Lam, John Dorrance Minna · 2011 · Cancer Prevention Research
64. Cytisinicline vs. Varenicline in Tobacco Addiction: A Literature Review Focused on Emotional Regulation, Psychological Symptoms, and Mental Health
    Oscar Fraile‐Μartinez, Cielo García Montero, Miguel Angel Ortega, Andrea Varaona, Luís Gutiérrez-Rojas, Melchor Álvarez‐Mon, Miguel Ángel Álvarez-Mon · 2025 · Healthcare
65. Smoking cessation by combined medication and counselling: a feasibility study in lung cancer patients
    Christian Reinhardt, Markus Harden, Christoph Herrmann‐Lingen, Achim Rittmeyer, Stefan Andreas · 2022 · BMC Pulmonary Medicine
66. Lung Cancer Screening—Trends and Current Studies
    Aleksandra Izabela Czerw, Andrzej Deptała, Olga Partyka, Monika Pajewska, Ewa Wiśniewska, Katarzyna Sygit, Sławomir Wysocki, Elżbieta Cipora, Magdalena Konieczny, Tomasz Banaś et al. · 2024 · Cancers
67. How stable are stop smoking practitioner success rates over time?
    Leonie S. Brose, Robert West, Andy McEwen · 2014 · Translational Behavioral Medicine
68. Seven-Day Continuous Abstinence Rate from Smoking at 1, 2, or 3 Years after the Use of Varenicline
    Jin Se Kim, Ju Young Jang, Eun Hye Park, Joo Young Lee, Kang-Mo Gu, Jae‐Woo Jung, Jae Chol Choi, Jong Wook Shin, In Won Park, Byoung Whui Choi et al. · 2015 · Tuberculosis & respiratory diseases
69. Minimal Structural Changes Determine Full and Partial Nicotinic Receptor Agonist Activity for Nicotine Analogues
    Juan Pablo González-Gutiérrez, Martín Hödar-Salazar, Franco Viscarra, Pablo Paillali, Nicolás Guerra-Díaz, Hernán Armando Pessoa-Mahana, Juan José Hernández Morante, Horacio Pérez‐Sánchez, Isabel Bermúdez, Miguel Iván Reyes-Parada et al. · 2019 · Molecules
70. Identifying sequential episodes of pharmacotherapy as a method for assessing treatment failure in comparative effectiveness research
    Greg Carney, Malcolm Maclure, Ken L. Bassett, Suzanne Taylor, Colin R. Dormuth · 2019 · Pharmacoepidemiology and Drug Safety
71. Smoking-Specific Risk Factors in Early Adulthood That Mediate Risk of Daily Smoking by Age 29 for Children with ADHD
    Jessica D. Rhodes, Traci M. Kennedy, Christine A. P. Walther, Elizabeth M. Gnagy, William E. Pelham, Brooke S. G. Molina · 2021 · Journal of Attention Disorders
72. The Usability of an Online Tool to Promote the Use of Evidence-Based Smoking Cessation Interventions
    Daniëlle N. Zijlstra, Catherine A. W. Bolman, Jean W. M. Muris, Hein de Vries · 2021 · International Journal of Environmental Research and Public Health
73. TOBACCO USE DISORDER AND DUAL DISORDERS Joint statement by the Spanish Psychiatry Society and the Spanish Dual Disorders Society.
    Néstor Szerman, Parro Carlos, Cristina Pinet, José Martínez-Raga, Ignacio Basurte, Pilar A. Sáiz · 2022 · Actas Españolas de Psiquiatría
74. The Role of Physiotherapists in Smoking Cessation Management: A Scoping Review
    Mohammad Z. Darabseh, Aseel Aburub, Eman Elsayed Fayed · 2023 · Healthcare
75. Effectiveness of nicotine salt vapes, cytisine, and a combination of these products, for smoking cessation in New Zealand: protocol for a three-arm, pragmatic, community-based randomised controlled trial
    Natalie K. Walker, Amanda Jane Calder, Joanne Barnes, George Robert Laking, Varsha Parag, Chris Bullen · 2023 · BMC Public Health
76. Unveiling the Impact of Electronic Cigarettes (EC) on Health: An Evidence-Based Review of EC as an Alternative to Combustible Cigarettes
    Sanjeev Balappa Khanagar, Farraj Albalawi, Aram Alshehri, Mohammed Adel Awawdeh, Kiran Iyer, Laliytha Kumar Bijai, Ali Aldhebaib, Oinam Gokulchandra Singh · 2024 · Cureus
77. Prescripción de fármacos para la deshabituación tabáquica. Análisis retrospectivo del área de salud de Zamora
    Raúl Majo García, Daniel Fernández-García, Maria Nélida Fernández-Martínez, María Guadalupe Espinosa Villoria, Laura Amaro Rodríguez, Manuel Angel Ruiz Cimarras · 2024 · Atención Primaria
78. Cytisine for smoking cessation in hospitalised smokers with cardiovascular diseases: an observational study
    Erika Tedesco, Sofia Ceccato, Alessandro Torazzi, Laura Santin, Lorenzo Losso, Andrea Bottardi, Rebecca Casari, Silvia Melchiori, Erica Secchettin, Valeria Ferrero et al. · 2025 · Internal and Emergency Medicine
79. Smoking and bladder cancer: insights into pathogenesis and public health implications from a bibliometric analysis (1999–2023)
    Yang Wang, Hancheng Zhou, Zhicheng Tang, Zhaohui He, Hui Zhuo, Yi Huang, Jianqiu Kong · 2025 · Substance Abuse Treatment Prevention and Policy
80. A 28-Day Challenge to Help Quit Smoking Using Telephone Follow-Ups Combined With the WeChat App
    Sisi Zhang, Qian Ding, Jun Shen, Heming Qu, Xiaoping Meng · 2021 · Journal of Addictions Nursing
81. Przewlekła obturacyjna choroba płuc u kobiet
    Romana Ucińska, Iwona Damps-Konstańska, Alicja Siemińska, Ewa Jassem · 2012 · Advances in respiratory medicine
82. PREDICTORS OF QUIT SUCCESS IN BELGIAN PARTICIPANTS OF A VARENICLINE OBSERVATIONAL SMOKING CESSATION STUDY
    Hedwig Boudrez, J-P Hoengenaert, Kris L. Nackaerts, Michael Messig, M Metcalfe · 2013 · Acta Clinica Belgica
83. Preventing adolescents' uptake of smoking
    Tim J Coleman, Linda Bauld · 2011 · Thorax
84. Aide à l’arrêt du tabagisme chez les personnes âgées
    P. Dupont, Lisa Blecha · 2011 · NPG. Neurologie, psychiatrie, gériatrie/NPG
85. Reflexiones sobre oportunidades de intervención en tabaquismo en Latinoamérica
    Gustavo Enrique Zabert, José Miguel Chatkin, Guadalupe Ponciano‐Rodríguez · 2010 · Salud Pública de México
86. Rehabilitation (EACPR) Developed with the special contribution of the European Association for Cardiovascular Prevention & Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) : The Fifth
    Christiaan J. Vrints, David Wood, José Luis Zamorano, Faiez M. Zannad, Şehnaz Karadeniz, Alessandro Mezzani, Eva Prescott, Shah B J Ebrahim, Giuseppe Germanò, Richard F. Hobbs et al. · 2013
87. Pharmacological Management of People Living with End-Stage Chronic Obstructive Pulmonary Disease
    Victoria Dalgliesh, Hilary Pinnock · 2017 · Drugs & Aging
88. The role of doctors in smoking cessation: evidence from the Cochrane Library
    Tim Lancaster · 2017 · SA Heart
89. Tobacco Addiction
    Stephan Muehlig · 2011 · InTech eBooks
90. Zalecenia Polskiego Towarzystwa Chorób Płuc Dotyczące Rozpoznawania i Leczenia Przewlekłej Obturacyjnej Choroby Płuc (POChP)
    Dorota Górecka, Ewa Jassem, Władysław Pierzchała, Paweł Śliwiński · 2012 · Advances in respiratory medicine
91. Smoking Cessation for the Busy Clinician
    Alan J. Zillich · 2007
92. Smoking Cessation for Cardiac Patients
    Ellen A. Dornelas, Paul D. Thompson · 2007 · Preventive Cardiology
93. Cost-effectiveness of pharmacotherapy for smoking cessation
    Lion Shahab · 2011 · UCL Discovery (University College London)
94. Development of Nicotine Loaded Chitosan Nanoparticles for Lung Delivery
    Hui Wang · 2017 · Queensland University of Technology
95. Eficacia y seguridad de vareniclina en el abandono del tabaquismo
    S. Solano Reina, P. Vaquero Lozano, Raquel Solano García-Tenorio, J.C. Márquez Nieto, José Ignacio de Granda Orive, Carlos Andrés Jiménez Ruiz · 2012 · Revista de Fomento Social
96. Control de los factores de riesgo y tratamiento de la enfermedad arterial oclusiva
    Carme Llort Pont, Albert Benet i Clarà · 2009 · Anales de Cirugía Vascular
97. Acute Ischemic Stroke
    Agnieszka Anna Ardelt · 2009 · Humana Press eBooks
98. An assessment of factors associated with quality of randomized controlled trials for smoking cessation
    Hong Fan, Fujian Song, Hai Gu, Jianming Wang, Guizhen Jia, Moyuan Lu, Jiao Qian, Lei Wang, Jiemiao Shen, zhewen ren · 2016 · Oncotarget
99. The implementation of health care aimed at the cessation of tobacco use, treatment of tobacco dependence and consequences of tobacco consumption in the Russian Federation
    Sergey Anatol'evich Boytsov, P. K. Yаblonskiy, M. G. Gambaryan, Olga Sukhovskaya, Oksana M. Drapkina · 2016 · Rational Pharmacotherapy in Cardiology
100. First Episode of Psychosis in the Context of Varenicline Treatment for Smoking Cessation
     Yuri Zoghbi, Raja Barazi, Menatalla Abdelkader, Yassin Hassan Eltorki, Suhaila Ghuloum · 2023 · Cureus